Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Causal inference in a clinical trial: a comparative example.

D F Heitjan1

  • 1Division of Biostatistics, Joseph L. Mailman School of Public Health, Columbia University, New York, New York 10032, USA. dfh5@columbia.edu

Controlled Clinical Trials
|August 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT.

Bone marrow transplantation·2012
Same author

Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.

The pharmacogenomics journal·2008
Same author

Long-term use of a left ventricular assist device for end-stage heart failure.

The New England journal of medicine·2002
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

Analyzing clinical trial data with treatment noncompliance requires careful method selection. Different analysis techniques yield substantially different results, impacting conclusions for immunosuppressive therapy trials.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Immunosuppressive Therapy

Background:

  • Noncompliance in clinical trials complicates treatment effect analysis.
  • Accurate interpretation of trial outcomes is crucial for patient care.

Purpose of the Study:

  • To compare various analytical methods for clinical trial data with noncompliance.
  • To highlight the impact of different analytical approaches on study conclusions.

Main Methods:

  • Applied as-randomized (intention-to-treat) analysis.
  • Conducted as-treated analysis.
  • Utilized nonignorable selection models and Rubin's causal model.

Main Results:

  • Substantial differences in results were observed across methods, even with modest noncompliance.

Related Experiment Videos

  • The choice of analysis method significantly influenced the interpretation of treatment effects.

    • Conclusions:

    • Data analysts must be explicit about the parameters of greatest importance in clinical trial analysis.
    • Methodological clarity is essential for reliable conclusions in trials with treatment noncompliance.